Back to Search
VICTORIA SLOAN, PH.D
PH.D
Clinical Psychologist
NPI: 1043205198Individual
Specialties, Licenses & Credentials
Research & Publications (11)
Standardizing assessment and reporting of adverse effects in rheumatology clinical trials II: the Rheumatology Common Toxicity Criteria v.2.0.
PMID 17552067·J Rheumatol·2007
8-other
Lumiracoxib is effective in the treatment of osteoarthritis of the knee: a prospective randomized 13-week study versus placebo and celecoxib.
PMID 16132165·Clin Rheumatol·2006
4-observational
Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis.
PMID 16645968·Arthritis Rheum·2006
2-rct
Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib.
PMID 15899100·Curr Med Res Opin·2005
3-trial
Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
PMID 16199245·Clin Ther·2005
1-meta
Lumiracoxib in the treatment of osteoarthritis, rheumatoid arthritis and acute postoperative dental pain: results of three dose-response studies.
PMID 15881487·Curr Med Res Opin·2005
8-other
Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo.
PMID 15763607·Clin Ther·2005
3-trial
Efficacy, safety and tolerability of lumiracoxib in patients with rheumatoid arthritis.
PMID 15605667·Int J Clin Pract·2004
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 7447 HARWIN DR, STE 215A
HOUSTON, TX 77036 - Phone
- (713) 521-2155
Quick Facts
- NPI
- 1043205198
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 11
Are you this provider?
Claim Your Profile